Stock Analiz

GoodRx Holdings, Inc. (GDRX) earnings: date, estimates and history

Price $3.56 · data as of November 13, 2026

Next earnings report

Next reportNov 17, 2026
QuarterSep/2026
EPS estimate$0.04
Revenue estimate—
Expected EPS growth—

Track record

Beat EPS estimates1 of 4
Average surprise−3.9%
Average move on report day±8.7%

GoodRx beat the consensus earnings estimate in 1 of its last 4 reports, by −3.9% on average. On report days the stock moved 8.7% on average, up or down.

Earnings history

ReportedEPS estimateEPS actualSurpriseRevenueRevenue growthStock move
November 3, 2026
Sep/2026
$0.04$0.04———+4.8%
August 5, 2026
Jun/2026
$0.08$0.08+0.4%$200M−1.3%+11.4%
May 6, 2026
Mar/2026
$0.07$0.07−2.2%$194M−4.4%+10.9%
February 25, 2026
Dec/2025
$0.09$0.09−1.7%$195M−1.9%−16.0%
November 4, 2025
Sep/2025
$0.09$0.08−12.3%$196M+0.4%+0.6%

EPS as compared with analyst estimates (adjusted EPS). Revenue growth is against the same quarter a year earlier. Stock move: change on the first trading day after the report.

Frequently asked questions

When is GoodRx’s next earnings date?

GoodRx is expected to report on November 17, 2026 (quarter Sep/2026).

What EPS do analysts expect next quarter?

The consensus estimate is $0.04 per share.

Report dates and estimates from analyst consensus data; results from company reports. Updated daily. Not investment advice. Earnings calendar